UC Davis’ Hemant Bhargava offers solutions to rising drug prices
New research from Distinguished Professor Hemant Bhargava finds female doctors pick lower-cost drugs more often—and offers four ways to cut costs: transparency, decision tools, targeting expensive drugs, and smart prescribing.
For medications available in multiple formulations, are there significant price differences between formulations, and what are the opportunity for savings if prescribers ordering the more expensive formulation switched to the less expensive
Physician productivity is an important driver of key healthcare outcomes, such as quality of care, treatment costs and patient satisfaction, because physicians influence a vast majority of treatment decisions, and are central to the care delivery
Despite the high volume of health care expenditures, it is often characterized by pricing opacity, leaving consumers in the dark when making critical healthcare decisions. Here, we examine the implications of price transparency, that is emerging on
The rapid proliferation of mobile health solutions has slowly integrated into the healthcare landscape, creating medical value through diverse ways. To understand these potential impacts, we propose a more detailed framework, specifically for
Because patients may receive care at multiple institutions within a region, “single-site” studies may under - or over-represent key clinical features such as the number of affected patients, the severity of disease, or the extent of treatment